Brenton Karl Ahrens, Director at Iterum Therapeutics plc (ITRM), sold 45,000 shares at $2.10 ($94K) on 2022-09-14, disclosed to the SEC on 2022-09-15.
Open-market sale of $94k ITRM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.14 | 15,000 | $32K | 34.2% |
| 2 | $2.10 | 15,000 | $32K | 33.5% |
| 3 | $2.02 | 15,000 | $30K | 32.3% |
| Total | $2.09 avg | 45,000 | $94K | 100% |
| Filing → |
| ITRM | BUY | 2018-05-30 | $6.6M | — | Filing → |
| DRTX | BUY | 2012-07-26 | $5.0M | — | Filing → |
| ACTV | SELL | 2012-03-06 | $3.1M | — | Filing → |